Legacy CG LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Legacy CG LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 4th quarter, HoldingsChannel reports. The fund owned 9,367 shares of the healthcare conglomerate’s stock after acquiring an additional 452 shares during the quarter. UnitedHealth Group comprises approximately 1.9% of Legacy CG LLC’s portfolio, making the stock its 22nd biggest holding. Legacy CG LLC’s holdings in UnitedHealth Group were worth $4,931,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of UNH. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Morgan Stanley increased its holdings in UnitedHealth Group by 13.8% in the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC increased its holdings in UnitedHealth Group by 100,076.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Alliancebernstein L.P. increased its holdings in UnitedHealth Group by 3.5% in the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after acquiring an additional 399,739 shares during the last quarter. Finally, Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at $5,210,004,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.7 %

Shares of NYSE UNH traded up $7.26 during midday trading on Monday, reaching $446.46. 3,847,458 shares of the company’s stock traded hands, compared to its average volume of 4,281,568. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock’s 50 day simple moving average is $492.29 and its 200-day simple moving average is $516.34. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a market cap of $411.60 billion, a price-to-earnings ratio of 18.74, a P/E/G ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the company posted $5.34 earnings per share. The business’s quarterly revenue was up 14.1% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.68%. UnitedHealth Group’s payout ratio is presently 31.54%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Finally, HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a research note on Thursday, April 4th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $573.80.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.